Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Remodeling the Tumor Myeloid Landscape to Enhance Antitumor Antibody Immunotherapies. | Cancers (Basel) | 2021 | 34638388 | PubTator, text mining | PubMed |
| Revisiting an IgG Fc Loss-of-Function Experiment: the Role of Complement in HIV Broadly Neutralizing Antibody b12 Activity. | mBio | 2021 | 34634936 | PubTator, text mining | PubMed |
| Analysis of Immune-Stromal Score-Based Gene Signature and Molecular Subtypes in Osteosarcoma: Implications for Prognosis and Tumor Immune Microenvironment. | Front Genet | 2021 | 34630511 | PubTator, text mining | PubMed |
| Pattern Recognition Proteins: First Line of Defense Against Coronaviruses. | Front Immunol | 2021 | 34630377 | PubTator, text mining | PubMed |
| Calcium-dependent signalling in B-cell lymphomas. | Oncogene | 2021 | 34625709 | PubTator, text mining | PubMed |
| Transcriptome Analysis Identifies Altered Biological Processes and Novel Markers in Human Immunodeficiency Virus-1 Long-Term Non-Progressors. | Infect Chemother | 2021 | 34623779 | PubTator, text mining | PubMed |
| Identification of immunization-related new prognostic biomarkers for papillary renal cell carcinoma by integrated bioinformatics analysis. | BMC Med Genomics | 2021 | 34620162 | PubTator, text mining | PubMed |
| Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection. | Hum Vaccin Immunother | 2021 | 34613865 | PubTator, text mining | PubMed |
| An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models. | Sci Transl Med | 2021 | 34609205 | PubTator, text mining | PubMed |
| Contribution to HIV Prevention and Treatment by Antibody-Mediated Effector Function and Advances in Broadly Neutralizing Antibody Delivery by Vectored Immunoprophylaxis. | Front Immunol | 2021 | 34603314 | PubTator, text mining | PubMed |
| Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus. | Front Endocrinol (Lausanne) | 2021 | 34603198 | PubTator, text mining | PubMed |
| Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer. | Breast Cancer (Dove Med Press) | 2021 | 34602823 | PubTator, text mining | PubMed |
| Inhibitory Fcγ Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease. | J Alzheimers Dis | 2021 | 34602489 | PubTator, text mining | PubMed |
| G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy. | Sci Adv | 2021 | 34586841 | PubTator, text mining | PubMed |
| Targeting B cells in the pre-phase of systemic autoimmunity globally interferes with autoimmune pathology. | iScience | 2021 | 34585117 | PubTator, text mining | PubMed |
| Therapeutic efficacy of probiotic Alkalihalobacillus clausii 088AE in antibiotic-associated diarrhea: A randomized controlled trial. | Heliyon | 2021 | 34585011 | PubTator, text mining | PubMed |
| Combination strategies to maximize the benefits of cancer immunotherapy. | J Hematol Oncol | 2021 | 34579759 | PubTator, text mining | PubMed |
| Thousands of CpGs Show DNA Methylation Differences in ACPA-Positive Individuals. | Genes (Basel) | 2021 | 34573331 | PubTator, text mining | PubMed |
| HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function. | Front Immunol | 2021 | 34566999 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Identifies New Inflammation-Promoting Cell Subsets in Asian Patients With Chronic Periodontitis. | Front Immunol | 2021 | 34566966 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=60